IL17A and psoriasis: A20, a component of PANoptosome, exerts an anti-inflammatory effect by interfering the activation of PANoptosome.[8] Researchers found A20 may reduce inflammation in psoriasis by restricting IL-23/IL-17 pathway.[18] Taken together, PANoptosis might be closely coupled with the pathogenesis of psoriasis.